Razieh Soltani Arabshahi, MD
MOHS-Micrographic Surgery · Pasadena, CANPI 1033423413
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 247 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations.
Across 247 payments — averaging $25.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$1K
- AbbVie$937
- Regeneron Healthcare Solutions, Inc.$634
- Sun Pharmaceutical Industries Inc.$483
- Johnson & Johnson$366
- Galderma Laboratories, L.p.$350
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,22397%
- Education$1713%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 35 | $1,292 |
| AbbVie(2 entities) | 47 | $937 |
| Regeneron Healthcare Solutions, Inc. | 19 | $634 |
| Sun Pharmaceutical Industries Inc. | 23 | $483 |
| Johnson & Johnson | 11 | $366 |
| Galderma Laboratories, L.p. | 12 | $350 |
| LEO Pharma Inc. | 17 | $343 |
| Incyte Corporation | 13 | $278 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $257 |
| E.r. Squibb & Sons, L.L.C. | 9 | $193 |
| Pfizer | 9 | $162 |
| Organogenesis Inc. | 6 | $156 |
| VYNE Pharmaceuticals Inc. | 3 | $151 |
| Biofrontera Inc. | 6 | $140 |
| Lilly USA, LLC | 4 | $85 |
| Revance Therapeutics, Inc. | 1 | $68 |
| Bioventus LLC | 2 | $58 |
| Genentech USA, Inc. | 4 | $57 |
| Arcutis Biotherapeutics, Inc. | 2 | $44 |
| Bristol Myers Squibb | 2 | $38 |
| Prugen, Inc. Pharmaceuticals | 2 | $36 |
| Dermavant Sciences, Inc. | 2 | $34 |
| Dermira, Inc. | 1 | $25 |
| UCB, Inc. | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $23 |
| Misonix Inc | 1 | $23 |
| Lifenet Health | 1 | $23 |
| Almirall LLC | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $21 |
| Aclaris Therapeutics, Inc. | 1 | $17 |
| EPI Health, LLC | 1 | $16 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,393 in reported general payments places this provider in the 75th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 14 | $100,980 |
| Fluorouracil | 62 | $4,346 |
| Clobetasol Propionate | 19 | $1,386 |
| Ketoconazole | 53 | $995 |
| Fluocinonide | 24 | $867 |
| Triamcinolone Acetonide | 85 | $776 |
| Metronidazole | 14 | $683 |
| Doxycycline Hyclate | 33 | $619 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 19 | $461 |
| Fluconazole | 21 | $391 |
| Betamethasone Dipropionate | 14 | $373 |
| Mupirocin | 52 | $290 |
| Doxycycline Monohydrate | 11 | $249 |
| ValacyclovirValacyclovir Hcl | 18 | $240 |
| Minoxidil | 17 | $213 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Pasadena
- Sarah ArronBurlingame$98K
- Daniel Zelacla Jolla$43K
- Ralph MasseySanta Monica$38K
- Michael MortazieOrange$29K
- Sumaira AasiStanford$27K
- Andrea WilleySacramento$21K
- Benjamin Kelleyla Jolla$20K
- Frank NoodlemanSaratoga$19K
- Howard FeinRolling Hills Estates$19K
- Joanna ChanLong Beach$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.